What are the most common nephrotoxic (kidney damaging) drugs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 10, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Guidelines

The most common nephrotoxic drugs include aminoglycoside antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), ACE inhibitors and ARBs, certain chemotherapeutic agents, contrast media, calcineurin inhibitors, amphotericin B, vancomycin, and acyclovir, which can cause kidney damage through various mechanisms, including direct tubular toxicity, altered hemodynamics, crystal formation, or immune-mediated injury, as reported in the 2020 Kidney International study 1.

Nephrotoxic Drugs and Their Mechanisms

These medications can damage the kidneys through different mechanisms, including:

  • Direct tubular toxicity, as seen with aminoglycosides, which accumulate in renal tubular cells causing direct damage 2
  • Altered hemodynamics, as seen with NSAIDs, which reduce prostaglandin production, decreasing renal blood flow 1
  • Crystal formation, as seen with certain chemotherapeutic agents, such as methotrexate 2
  • Immune-mediated injury, as seen with immune checkpoint inhibitors, which can cause acute kidney injury (AKI) and proteinuria 2

High-Risk Patients and Prevention Strategies

Patients with pre-existing kidney disease, diabetes, heart failure, advanced age, or dehydration are at higher risk for drug-induced nephrotoxicity 1. To minimize kidney damage, the following strategies can be employed:

  • Monitoring kidney function through serum creatinine and estimated glomerular filtration rate is essential when using these medications, especially in high-risk patients 1
  • Dose adjustments, adequate hydration, and avoiding combinations of nephrotoxic drugs can help minimize kidney damage 1
  • Drug stewardship, with a primary goal of balancing the changing risks and benefits of drug utilization and dosing in AKI/AKD, is critical in preventing or mitigating drug-associated kidney injury or dysfunction 1

From the FDA Drug Label

As with other aminoglycosides, gentamicin injection is potentially nephrotoxic. Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as cisplatin, cephaloridine, kanamycin, amikacin, neomycin, polymyxin B, colistin, paromomycin, streptomycin, tobramycin, vancomycin and viomycin, should be avoided.

The most common nephrotoxic drugs include:

  • Aminoglycosides: such as gentamicin, kanamycin, amikacin, neomycin, streptomycin, and tobramycin
  • Other nephrotoxic agents: such as cisplatin, cephaloridine, polymyxin B, colistin, paromomycin, vancomycin, and viomycin 3

From the Research

Nephrotoxic Drugs

The following are some of the most common nephrotoxic drugs:

  • Antimicrobials, antihypertensives, and nonsteroidal anti-inflammatory drugs (NSAIDs) are common offenders of drug-induced kidney injury 4
  • Immunosuppressive medications, statins, proton pump inhibitors, and herbal supplements can also cause kidney damage 4
  • NSAIDs, diuretics, ACE inhibitors, and angiotensin II receptor blockers (ARBs) are the most frequent prerenal causes of an acute elevation in creatinine levels 5
  • Aminoglycosides, vancomycin, and radiocontrast agents can cause tubulopathies 5
  • Cyclosporin, tacrolimus, and muromonab-CD3 can cause primary vascular damage 5

Drug-Specific Nephrotoxicity

  • Aminoglycosides are associated with nephrotoxicity, especially in older patients, and can cause acute kidney injury (AKI) 6, 7
  • NSAIDs can lead to AKI, especially in the elderly, and can also cause chronic kidney disease (CKD) with long-term use 8, 7
  • Cyclosporin can cause vasoconstriction of the afferent arteriole, leading to a lower glomerular filtration rate (GFR), and can also result in nephrotoxicity in combination therapy 7

Risk Factors for Nephrotoxicity

  • Older patients with multiple comorbidities and polypharmacy are at increased risk of nephrotoxicity 4
  • Concomitant use of nephrotoxic drugs increases the risk of kidney damage 4, 6
  • High doses of NSAIDs and aminoglycosides can increase the risk of AKI 8, 7

Related Questions

What is the effect of Aleve (Naproxin) on Chronic Kidney Disease (CKD)?
Which antihypertensive agents should be avoided in a patient with acute kidney injury superimposed on end-stage renal disease?
Which of the following medications are nephrotoxic: albuterol inhaler, low‑dose aspirin 81 mg daily, atorvastatin 40 mg daily, bupropion 150 mg daily, carvedilol 6.25 mg twice daily, citalopram 40 mg daily, vitamin D2 50 000 units weekly, furosemide 40 mg daily, glipizide 10 mg daily, levothyroxine 25 µg daily, losartan 25 mg daily, tirzepatide 10 mg weekly, pregabalin 75 mg twice daily, insulin glargine U‑300 15 units daily?
Can aminoleban be given to a patient with impaired renal function?
In an adult with new‑onset acute kidney injury, interstitial nephritis, electrolyte abnormalities, uric‑acid nephropathy, and suspected drug‑induced nephrotoxicity, what is the most likely cause and recommended management?
What is the process for calculating donor lymphocyte collection using Apheresis (Automated Peripheral Blood Hematopoietic Progenitor Cell Collection)?
What is the role of Atropine (antimuscarinic agent) in managing secretions?
What does the Pneumococcal (Streptococcus pneumoniae) vaccine protect against?
What is the physiology behind carbon dioxide (CO2) concentration in the respiratory system?
What is the effect of Glipizide (Glipizide) on zinc transport with positive zinc transporters?
What is the recommended delay for chemotherapy after Open Reduction Internal Fixation (ORIF) of a pathological fracture?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.